News
Longitudinal evaluation of SNOT-22 can distinguish patients with chronic rhinosinusitis with nasal polyps who respond quickly ...
Doctors at Huntsman Cancer Hospital removed the 36-year-old woman’s real stomach less than two weeks ago, a preventive ...
4d
MedPage Today on MSNAI Topped Docs in Quality, Empathy of Responses to Patient Questions on GI CancersOn a 5-point Likert scale, AI responses scored a 4.2 on both quality and empathy compared with scores of 3.0 on quality and 2 ...
Q1 2025 Earnings Call Transcript May 8, 2025 Insmed Incorporated misses on earnings expectations. Reported EPS is $-1.42 EPS, ...
1d
Medindia on MSNCould Cannabis Be Making Colon Cancer More Deadly?People with colon cancer and a history of heavy cannabis use are over 20 times more likely to die within five years than ...
Cancer related studies were among nearly 6,000 abstracts presented at Digestive Disease Week® (DDW) 2025, including research ...
Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.
8d
Dropbox on MSNZoanthids - colonial organisms - a whole new type of animal!Zoanthids are anemone like animals but occur in sheets where each polyp is genetically identical and part of the larger ...
Cases of pancreatic cancer have increased significantly among younger individuals compared with those aged 35 years and older ...
Chronic rhinosinusitis with nasal polyps (CRSwNP) inflammatory endotypes are associated with long-term air pollutant and allergen exposure.
Lyra Therapeutics, Inc. (Nasdaq: LYRA) ("Lyra" or the "Company"), a clinical-stage biotechnology company developing long-acting, anti-inflammatory sinonasal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results